-
admin
Posts
Adoption of an Exclusive Human Milk Diet Reduces Malnutrition Rates Among Vulnerable Premature Infants in Sydney Hospital
Preliminary Data From Observational Study Presented at Australian and New Zealand Neonatal Network Clinical Practice Improvement Conference ADELAIDE, Australia, Dec. 10, 2024 /PRNewswire/ — Prolacta...
Cosmetic Manufacturing Market to Reach US$ 878.88 Billion by 2034, Growing at 6.4% CAGR | Fact.MR Report
Need for Cosmetic Manufacturing Growing All Around the World on Back of Social Media and Beauty Influencers Rockville, MD , Dec. 09, 2024 (GLOBE NEWSWIRE)...
Hair Wigs & Extensions Market Focused Insights 2024-2029 – Godrej, Klix Hair Extensions, Great Lengths and Evergreen Product Group are Leading the Market
Dublin, Dec. 09, 2024 (GLOBE NEWSWIRE) — The “Hair Wigs & Extensions Market – Focused Insights 2024-2029” report has been added to ResearchAndMarkets.com’s offering. The...
Jetex announced as the exclusive operator of Red Sea International Airport’s Private Jet Terminal
Jetex to operate RSI’s private aviation terminal following agreement with daa International Riyadh, Dec. 09, 2024 (GLOBE NEWSWIRE) — Red Sea Global (RSG), the developer...
BeautyRightBack Launches New Subscription Service for Beauty Services
BeautyRightBack launches an AI-powered subscription service offering unlimited beauty treatments for a flat fee. Designed to enhance accessibility and streamline salon operations, the service uses...
Zelixir’s New Factory to Revolutionize Natural Fragrance Production with ‘AI+Synthetic Biology’
SHANGHAI, Dec. 08, 2024 (GLOBE NEWSWIRE) — Shanghai Zelixir Biotechnology Co., Ltd. (“Zelixir”) today announced the official operation of its cutting-edge green manufacturing plant in...
AiViva Biopharma Receives FDA Clearance to Administer AIV001 in Facial Skin by Intradermal Injection for Nonmelanoma Skin Cancer
AIV001 is currently in development for evaluation in Superficial and Nodular Superficial Basal Cell Carcinoma (sBCC and nBCC) COSA MESA, Calif., Dec. 09, 2024 (GLOBE...
EnnoDC presents preliminary data for immunotherapy candidate CD40.HVac in HPV+ oropharyngeal cancer at ESMO IO 2024
PRESS RELEASE EnnoDC presents preliminary data for immunotherapy candidate CD40.HVac in HPV+ oropharyngeal cancer at ESMO IO 2024 Paris, France, 9 December 2024 – EnnoDC,...
Corbus Pharmaceuticals Announces Dosing of First Patient in its First-In-Human Study of CRB-601 to Treat Patients with Advanced Solid Tumors
CRB-601 is an anti-αvβ8 monoclonal antibody designed to block activation of latent TGFβ in the tumor micro-environment NORWOOD, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) —...
Auron Presents New Preclinical Data for AUTX-703 in AML at ASH Annual Meeting
Data demonstrate dose dependent survival advantage with AUTX-703 in primary patient-derived orthotopic AML model IND submissions on track for late 2024 NEWTON, Mass., Dec. 09,...
